Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor
Stem Cell Research & Therapy2013Vol. 4(5), pp. 103–103
Citations Over TimeTop 10% of 2013 papers
Diangeng Li, Nan Wang, Li Zhang, Han-Yu Zhu, Xueyuan Bai, Bo Fu, Shaoyuan Cui, Weiguang Zhang, Xuefeng Sun, Rongshan Li, Xiangmei Chen
Abstract
hAd-MSCs prevent podocytic apoptosis and injury induced by HG, mainly through secreting soluble EG.
Related Papers
- → Mesenchymal stem cell therapy in treatment of erectile dysfunction: Autologous or allogeneic cell sources?(2014)32 cited
- → How and when are substrates selected for type III secretion?(2001)57 cited
- → Mesenchymal Stem/Stromal Cells: ASSESSING THE SAFETY AND TOXICITY OF VERY HIGH DOSES OF ALLOGENEIC HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS(2023)1 cited
- → Mesenchymal Stem/Stromal Cells: THE EFFECTS OF ADIPOSE TISSUE MESENCHYMAL STEM CELLS (AT-MSCS) ON IMMUNOLOGICAL PATTERNS IN FEMALES WITH MULTIPLE SCLEROSIS(2022)
- → Mesenchymal Stem/Stromal Cells: COMMENCEMENT OF FIRST-IN-HUMAN FOR CLINICAL TRIAL OF ADIPOSE TISSUE DERIVED ALLOGENEIC MESENCHYMAL STEM CELL (ADMSC) SHEETS FOR RETINAL DISEASES(2023)